Annabel provides consultancy on patient centered outcomes, specialising in FDA, EMA and HTA requirements for PROs and other clinical outcome assessments.

 

Annabel is an expert in patient centered outcomes, with 20 years’ international experience consulting in the pharmaceutical industry in Europe and the USA.

 

Annabel completed her PhD in 2001, which she undertook alongside a research fellow position at the London School of Hygiene and Tropical Medicine (LSHTM) before moving into a consultancy career that included Quintiles IMS (QI), Oxford Outcomes (now ICON), and PRMA Consulting.  Annabel was co-chair of the Drug Information Agency (DIA) Study Endpoints community (2012–2016). She has published many research papers and is  the lead author of ‘Patient Reported Outcomes: an overview’ (ebook, paperback), written with colleague Diane Wild.